Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2020 1
2021 2
2022 2
2023 2
2024 5
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Guanxin V alleviates acute myocardial infarction by restraining oxidative stress damage, apoptosis, and fibrosis through the TGF-beta1 signalling pathway.
Liang B, Zhang XX, Li R, Zhu YC, Tian XJ, Gu N. Liang B, et al. Phytomedicine. 2022 Jun;100:154077. doi: 10.1016/j.phymed.2022.154077. Epub 2022 Mar 27. Phytomedicine. 2022. PMID: 35395567
The lentiviral vector containing the full-length TGF-beta1 sequence was administered to investigate the rescue role of Guanxin V. RESULTS: Guanxin V significantly decreased apoptosis and inhibited oxidative stress damage and fibrosis in acute myocardial infarction. …
The lentiviral vector containing the full-length TGF-beta1 sequence was administered to investigate the rescue role of Guanxin V. RES …
Guanxin V attenuates myocardial ischaemia reperfusion injury through regulating iron homeostasis.
Zhou F, Zhang Z, Wang M, Zhu W, Ruan J, Long H, Zhang Y, Gu N. Zhou F, et al. Pharm Biol. 2022 Dec;60(1):1884-1898. doi: 10.1080/13880209.2022.2123934. Pharm Biol. 2022. PMID: 36215067 Free PMC article.
CONTEXT: Guanxin V (GX), a traditional Chinese medicine formula, is safe and effective in the treatment of coronary artery disease. ...
CONTEXT: Guanxin V (GX), a traditional Chinese medicine formula, is safe and effective in the treatment of coronary artery disease. . …
Effect of Guanxin V in animal model of acute myocardial infarction.
Zhang X, Shao C, Cheng S, Zhu Y, Liang B, Gu N. Zhang X, et al. BMC Complement Med Ther. 2021 Feb 22;21(1):72. doi: 10.1186/s12906-021-03211-7. BMC Complement Med Ther. 2021. PMID: 33618704 Free PMC article.
BACKGROUND: Acute myocardial infarction (AMI) is the most serious and lethal manifestation of coronary heart disease worldwide, presenting extremely high disability and mortality. Our previous studies have shown that Guanxin V (GXV) could significantly improve the cardiac …
BACKGROUND: Acute myocardial infarction (AMI) is the most serious and lethal manifestation of coronary heart disease worldwide, presenting e …
Guanxin V alleviates ventricular remodeling after acute myocardial infarction with circadian disruption by regulating mitochondrial dynamics.
Cheng S, Wu J, Pei Y, Tong H, Fan M, Xiang Q, Ding Y, Xie L, Zhang H, Sun W, Zhang X, Zhu Y, Gu N. Cheng S, et al. Sleep Breath. 2024 May;28(2):823-833. doi: 10.1007/s11325-023-02974-2. Epub 2023 Dec 26. Sleep Breath. 2024. PMID: 38147288
Ventricular remodeling (VR) is a pivotal progressive pathologic change after acute myocardial infarction (AMI) and circadian disruption may have a negative influence on VR according to the latest research. Whether or not Guanxin V (GXV) has a positive effect on VR after AM …
Ventricular remodeling (VR) is a pivotal progressive pathologic change after acute myocardial infarction (AMI) and circadian disruption may …
Comparative efficacy of different Chinese patent medicines in preventing restenosis after percutaneous coronary intervention: a systematic review and Bayesian network meta-analysis of randomized clinical trials.
Fan J, Li T, Pu F, Guo N, Wang J, Gao Y, Zhao H, Wang X, Zhu H. Fan J, et al. Front Pharmacol. 2024 Jan 5;14:1265766. doi: 10.3389/fphar.2023.1265766. eCollection 2023. Front Pharmacol. 2024. PMID: 38249344 Free PMC article.
Regarding angiographic restenosis, the efficacy of CPMs (except Xuezhikang capsule) combined with standard treatment (Std) was superior to Std alone, and Guanxin Shutong capsule plus Std reduced the risk of angiographic restenosis by 76% (relative risk 0.24, 95% confidence …
Regarding angiographic restenosis, the efficacy of CPMs (except Xuezhikang capsule) combined with standard treatment (Std) was superior to S …
11 results